Writing in the Journal of Prevention of Alzheimer’s Disease — the same place where Biogen published the Aduhelm manuscript — Schneider dissected the paper and blasted the central message as “so wrong on many levels.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,